Chronic Obstructive Pulmonary Disease COPD Clinical Trial
Official title:
Pulmonary Rehabilitation: Effects on Cognitive Functioning, Mood, Anxiety, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)
The purpose of this project is to investigate whether a 12-week, fulltime pulmonary rehabilitation program can enhance cognitive functioning, mood, anxiety, and quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02238483 -
A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy
|
Phase 2 | |
| Completed |
NCT03162055 -
Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Completed |
NCT03131362 -
Realize the Current Situation of COPD Patients in China
|
||
| Completed |
NCT02645253 -
A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men
|
Phase 1 | |
| Completed |
NCT02971293 -
Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871
|
Phase 2 |